Totality Of Available Data Reaffirms PROCRIT(R) (Epoetin Alfa) Is Safe And Effective When Used Appropriately As Labeled To Treat Anemia

The totality of scientific data submitted in recent months to the U.S. Food and Drug Administration (FDA) in preparation for the March 13th Oncologic Drugs Advisory Committee Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are safe and effective when used according to the product label to treat chemotherapy induced anemia (CIA). ESAs are an important treatment option for CIA patients as the only proven therapeutic alternative to blood transfusions.

More: continued here

Filed under: Blood on March 15th, 2008